Literature DB >> 3772804

Site and mechanism of growth inhibition by prostaglandins. I. Active transport and intracellular accumulation of cyclopentenone prostaglandins, a reaction leading to growth inhibition.

S Narumiya, M Fukushima.   

Abstract

Cyclopentenone prostaglandins (PGs) such as PGA2 or 9-deoxy-delta 9,12-13,14-dihydro-PGD2 (delta 12-PGJ2) induce growth inhibition of various lines of cultured cells. Action sites of these PGs were studied by incubating them with L-1210 murine leukemia cells. L-1210 cells accumulated both PGs in a time-dependent manner at 37 degrees C. When the uptake was analyzed with various concentrations of delta 12-PGJ2, the Michaelis-Menten type of kinetics was obtained, and the Km and Vmax were 250 microM and 2.5 nmol/min/10(6) cells, suggesting that the uptake was a carrier-mediated active transport. Competition studies with [3H]delta 12-PGJ2 showed that PGA2 was transported by the same carrier with a similar affinity. PGs without growth inhibitory activity such as PGD2, PGE2 and PGF2 alpha were neither taken up by the cells nor interfered the uptake. Subcellular distribution studies with sucrose density gradient centrifugation showed that transported delta 12-PGJ2 was present mainly in cytoplasm and nuclei without metabolism. Accumulation of the PG was attenuated greatly by preincubation of the cells at 37 degrees C for 30 min. When the effect of delta 12-PGJ2 was examined in the control and attenuated cells, a clear correlation was observed between the accumulation of the PG and its growth inhibitory effect. These results suggested that uptake and intracellular accumulation of cyclopentenone PGs are responsible for their growth inhibitory activity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3772804

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  20 in total

1.  Prostaglandin D(2), its metabolite 15-d-PGJ(2), and peroxisome proliferator activated receptor-gamma agonists induce apoptosis in transformed, but not normal, human T lineage cells.

Authors:  Sarah G Harris; Richard P Phipps
Journal:  Immunology       Date:  2002-01       Impact factor: 7.397

2.  Prostaglandin J2 promotes O-GlcNAcylation raising APP processing by α- and β-secretases: relevance to Alzheimer's disease.

Authors:  Teneka Jean-Louis; Patricia Rockwell; Maria E Figueiredo-Pereira
Journal:  Neurobiol Aging       Date:  2017-11-14       Impact factor: 4.673

3.  Redox signaling, alkylation (carbonylation) of conserved cysteines inactivates class I histone deacetylases 1, 2, and 3 and antagonizes their transcriptional repressor function.

Authors:  Kelly Doyle; F A Fitzpatrick
Journal:  J Biol Chem       Date:  2010-04-12       Impact factor: 5.157

4.  Preferential binding of growth inhibitory prostaglandins by the target protein of a carcinogen.

Authors:  S H Khan; S Sorof
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

5.  Effects of cytotoxic prostaglandin, delta 12-PGJ2 on protein synthesis and cytoskeleton in transformed epidermal cells in culture.

Authors:  K Ikai; M Fukushima
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

6.  Induction of MRP/GS-X pump and cellular resistance to anticancer prostaglandins.

Authors:  K Akimaru; M T Kuo; K Furuta; M Suzuki; R Noyori; T Ishikawa
Journal:  Cytotechnology       Date:  1996       Impact factor: 2.058

7.  Induction of HSP70 gene expression by the antiproliferative prostaglandin PGA2: a growth-dependent response mediated by activation of heat shock transcription factor.

Authors:  N J Holbrook; S G Carlson; A M Choi; J Fargnoli
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

8.  Subchronic infusion of the product of inflammation prostaglandin J2 models sporadic Parkinson's disease in mice.

Authors:  Sha-Ron Pierre; Marijke A M Lemmens; Maria E Figueiredo-Pereira
Journal:  J Neuroinflammation       Date:  2009-07-25       Impact factor: 8.322

9.  Alkylation of the tumor suppressor PTEN activates Akt and β-catenin signaling: a mechanism linking inflammation and oxidative stress with cancer.

Authors:  Tracy M Covey; Kornelia Edes; Gary S Coombs; David M Virshup; Frank A Fitzpatrick
Journal:  PLoS One       Date:  2010-10-21       Impact factor: 3.240

Review 10.  Preclinical studies of antitumor prostaglandins by using human ovarian cancer cells.

Authors:  Y Kikuchi; T Kita; J Hirata; M Fukushima
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.